My laboratory investigates the cellular and molecular mechanisms underlying pelvic floor disorders and develops therapies to restore tissue structure and function. Research areas include:
Molecular control of fibrosis: Define how mechanical forces and extracellular matrix stiffness activate fibroblasts and sustain fibrosis, with emphasis on integrin, Rho/ROCK, TGF-β/SMAD, and YAP/TAZ signaling as potential therapeutic targets.
Vaginal stem cell biology and regeneration: Investigate how vaginal stem cells maintain and repair the epithelium and how aging, hormonal changes, and the tissue microenvironment regulate their function.
Regenerative biomaterials: Develop extracellular matrix–derived bioscaffolds and hydrogels that modulate cell signaling, promote tissue repair, and redirect healing toward regeneration.
Mechanisms of implant-associated tissue injury: Determine how surgical mesh alters immune responses, cell–matrix interactions, and tissue remodeling to identify strategies that prevent fibrosis and implant complications.
Nonhormonal therapies for vaginal aging: Develop and evaluate treatments that restore vaginal tissue health, including approaches for women who cannot use estrogen.
Human models for therapeutic discovery: Develop vaginal organoids and vagina-on-a-chip systems to study epithelial–stromal interactions, hormonal responses, and mechanisms of therapeutic action.
Graduate students can combine molecular and cellular approaches, single-cell transcriptomics and epigenomics, tissue engineering, and preclinical models to identify therapeutic targets and test interventions relevant to women’s health.
